Aerial view of campus with Williamsport, the Susquehanna River and Bald Eagle Mountain as a backdrop

Pioneer in pharmaceutical research to deliver Lycoming College commencement address

Pioneer in pharmaceutical research to deliver Lycoming College commencement address

Download Image: Web

Dr. Lynn Kramer ’72, an executive leader, clinical neurologist, and pioneer in pharmaceutical research, will deliver a commencement address at Lycoming College’s 178th commencement ceremony in a celebration of the Class of 2026, on Saturday, May 9, at 2 p.m., on the historic Fultz Quadrangle. Kramer will be awarded an honorary Doctor of Science Degree during commencement exercises.

Kramer is chief clinical officer, Deep Human Biology Learning at Eisai Company Ltd., a Japan based pharmaceutical company, as well as a member of the executive committee. In these roles, he oversees the product creation cycle, including clinical introduction and regulatory approval of innovative projects for all Eisai products. Kramer’s extraordinary contributions to advancing Alzheimer’s treatments most recently garnered him recognition in Time Magazine’s Time100 Health in 2026 as one of the 100 most influential leaders in healthcare.

Kramer joined Eisai in 2007 as the executive vice president of global clinical research and was soon promoted to the additional role of chief operating officer of Eisai Medical Research. In early 2009, he was named president of the Scientific and Operational Clinical Support Core Function Unit and president of the Neuroscience Product Creation Unit. He was named chief clinical officer and a member of the executive committee of Eisai Company, Ltd., in 2012. In these roles he was responsible for regulatory functions, biostatistics, data management, medical writing, and clinical functions and clinical pharmacology, as well as modeling and simulations. During this time, he oversaw the development and regulatory approval of several new molecular entities.

Earlier in his career, Kramer held senior positions in drug development at companies including Novartis and the R.W. Johnson Pharmaceutical Research Institute. In addition, he held senior clinical and safety leadership positions with PAR Pharmaceutical, Purdue, and Carter-Wallace. Prior to his industry career, Kramer was Co-PI of a National Institutes of Health (NIH) sponsored epilepsy-focused program project in Los Angeles, Calif.

A dedicated member of the Lycoming College community, Kramer served the College on the board of trustees from 2012-2016. He is a Fellow of the American Board of Psychiatry and Neurology (1987) and the Philadelphia College of Physicians (1987). He previously served as the industry representative on the Peripheral and Central Nervous System Drugs Advisory Committee of the Food and Drug Administration (FDA) and on the Board of Directors at the American Society for Experimental Neuro Therapeutics (ASENT). He currently is a member of the Pharma R&D Leadership Forum. In 2022, he became the 12th recipient of the Epilepsy Foundation’s Lifetime Accelerator Award.

Kramer graduated from Lycoming College with a bachelor’s degree in interdisciplinary studies. He received a doctoral degree in medicine from Hahnemann Medical College (currently Drexel University), and completed his internship in internal medicine at the University of California at Irvine and his residency in neurology at the University of Virginia. Kramer is also a Fellow of the American Academy of Neurology. He resides in Florida and Connecticut with his wife, Lavonne. The couple has two adult children.

Anna Glantz to Deliver Senior Greeting

Graduating senior Anna Glantz, a music major with music and special education certifications, will deliver a greeting from the senior class at the ceremony. She was selected for this honor by the Senior Class Officers, and the faculty and staff who serve on the Senior Greeting Selection Committee.

During her four years on campus, Glantz has proven herself to be an effective leader, serving as class president four years in a row. She was a member of Student Senate for four years and served on other committees including Student Life. Glantz was a member of multiple campus groups and took on leadership roles for many, including Alpha Xi Delta, the Marathon Canoe Team, Lycoming College Choir and Tour Choir, and Lycoming College Band. She was on the women’s lacrosse team, founded the Lycoming College Larks.

Glantz was academically successful as well and was named to the Dean’s List all four years. She was a Haberberger Research Fellow and a WISE Intern, and was invited to join several honor societies including Omicron Delta Kappa Leadership Honor Society, Kappa Delta Pi Education Honor Society, Order of Omega Greek Leadership Honor Society and the IRUSKA Honor Society. She was awarded the Dr. Will George Butler Choral Award and the Williamsport Civic Chorus Award, and was the Delta Kappa Gamma Society of Women Educators Grant Recipient.

As a student, Glantz remained active in community service, participating in Service Saturdays, AXiD philanthropy work with Dwell Orphan Care, Central Elementary Family Night, Unity Day, Blue & Gold Day, Homecoming Weekend & Choir Alumni Events, Candlelight Services, 9/11 Days of Service, and STOA: a musical journey sensory friendly show. She also volunteered her time as the Pennsylvania Music Educators Association District 8 Collegiate Board Member. She also worked in multiple offices on campus, including Warriorthon, Admissions, the Tutoring Center, among others.

Glantz did her student teaching in the Montgomery and Montoursville area school districts. She completed a Switzerland summer study abroad for education system research. She plans to attend Berklee College of Music to pursue a master’s degree in music education with a focus in autism studies, continuing her Haberberger research while also beginning her teaching career.

More information about the event is available at: www.lycoming.edu/commencement/.